Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.

@article{Ganesan2011NonadherenceTI,
  title={Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.},
  author={Prasanth Ganesan and Tenali Gnana Sagar and Biswajit Dubashi and Rejiv Rajendranath and Krishnarathinam Kannan and Sanju Cyriac and Manjunath Nandennavar},
  journal={American journal of hematology},
  year={2011},
  volume={86 6},
  pages={471-4}
}
There is limited data on the impact of treatment interruptions due to nonadherence in patients with chronic phase chronic myeloid leukemia (CP-CML) treated with Imatinib. We looked at factors (including adherence to therapy) affecting the outcome in a large cohort of patients with CP-CML. All the 516 patients received Imatinib free-of-cost through a company sponsored scheme, which mandated regular three monthly visits for drug procurement. Data regarding the disease characteristics, adherence… CONTINUE READING
52 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Similar Papers

Loading similar papers…